Follow
Wim Verleyen
Wim Verleyen
Raytheon Technologies
Verified email at rtx.com
Title
Cited by
Cited by
Year
Guidance for RNA-seq co-expression network construction and analysis: safety in numbers
S Ballouz, W Verleyen, J Gillis
Bioinformatics 31 (13), 2123-2130, 2015
2332015
Measuring the wisdom of the crowds in network-based gene function inference
W Verleyen, S Ballouz, J Gillis
Bioinformatics 31 (5), 745-752, 2015
252015
An analytical approach differentiates between individual and collective cancer invasion
E Katz, W Verleyen, CG Blackmore, M Edward, VA Smith, DJ Harrison
Analytical cellular pathology 34 (1-2), 35-48, 2011
142011
Positive and negative forms of replicability in gene network analysis
W Verleyen, S Ballouz, J Gillis
Bioinformatics 32 (7), 1065-1073, 2016
112016
Framework for disruptive AI/ML Innovation
W Verleyen, W McGinnis
arXiv preprint arXiv:2204.12641, 2022
12022
Providence-a Deep Learning Framework for Time-to-Event Prediction
S Fox, E Zimmerman, T Daly, M O'Keeffe, W Verleyen
2022 IEEE Aerospace Conference (AERO), 1-10, 2022
2022
SAPLING: A TOOL FOR CUSTOMIZED NETWORK ANALYSIS FOCUSING ON PSYCHIATRIC GENETICS
W Verleyen, J Gillis
European Neuropsychopharmacology 27, S352-S353, 2017
2017
Novel Monte Carlo approach quantifies data assemblage utility and reveals power of integrating molecular and clinical information for cancer prognosis
W Verleyen, SP Langdon, D Faratian, DJ Harrison, VA Smith
Scientific Reports 5 (1), 15563, 2015
2015
Machine learning for systems pathology
W Verleyen
University of St Andrews, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–9